The role of stress in drug self-administration

Trends in Pharmacological Sciences

Volumn 19, Issue 2, 1998, Pages 67-74

  Piazza, P V ^a   Le Moal, M ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; COCAINE; DIAMORPHINE; DOPAMINE; GLUCOCORTICOID; MORPHINE; OPIATE; PSYCHOSTIMULANT AGENT;

ANIMAL BEHAVIOR; DOSE RESPONSE; DRUG ABUSE; DRUG SELF ADMINISTRATION; EXPERIMENTATION; HUMAN; IMPULSIVENESS; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; STRESS;

EID: 0031906165     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(97)01115-2     Document Type: Article

References (61)

1. O'Brien C. P., Ehrman R. N., Terns J. N. Goldeberg S. R., Stolerman I. P. Behavioral Analysis of Drug Dependence. 1986;p. 329 Academic Press.
2. Nestler E. J. J. Neurosci. 12:1992;2439-2450.
3. Robinson T. E., Berridge K. C. Brain Res. Rev. 18:1993;247-291.
4. White F. Addiction. 91:1996;921-949.
5. Piazza P. V., Le Moal M. Annu. Rev. Pharmacol. Toxicol. 36:1996;359-378.
6. Kosten T. R., Rounsaville B. J., Kleber H. D. Arch. Gen. Psychiatry. 43:1986;733-739.
7. O'Dohetry F. Drug Alcohol Depend. 29:1991;97-106.
8. Johanson C-E., Fischman M. W. Pharmacol. Rev. 41:1989;3-52.
9. Gawin F. H. Science. 251:1991;1580-1586.
10. O'Doherty F., Davies B. J. Br. J. Addict. 82:1987;127-137.
11. Weeks J. R. Science. 138:1962;143-144.
12. Yokel R. A. Bozarth M. A. Methods of Assessing the Reinforcing Properties of Abused Drugs. 1987;1-34 Spring-Verlag.
13. Altman J. et al. Psychopharmacology. 125:1996;285-345.
14. Schuster C. R., Thompson T. Annu. Rev. Pharmacol. 9:1969;483-502.
15. Shaham Y., Stewart J. Psychopharmacology. 111:1995;334-341.
16. Koob G. F., Bloom F. E. Science. 242:1988;715-723.
17. Wise R. A. Curr. Opin. Neurobiol. 6:1996;243-251.
18. McEwen, B. S., De Kloet, E. R. and Rostène, W. (1986) Physiol. Rev., 66, 1221-1188.
19. De Kloet E. R. Front. Neuroendocrinol. 12:1992;95-164.
20. Carrol M. E., Meich R. A. Adv. Behav. Pharmacol. 4:1984;47-88.
21. Kanarek R. B., Marks-Kaufman R. Kanarek R. B., Marks-Kaufman R., Van Nostrand R. Nutrition and Behavior. New Perspectives. 1988;1-25 Avi Books.
22. Piazza P. V., Deminière J. M., Le Moal M., Simon H. Brain Res. 514:1990;22-26.
23. Goeders N. E., Guerin G. F. Psychopharmacology. 114:1994;63-70.
24. Shaham Y., Stewart J. Psychopharmacology. 114:1994;523-527.
25. Erb S., Shaham Y., Stewart J. Psychopharmacology. 128:1996;408-412.
26. Shaham Y. Psychopharmacology. 111:1993;477-485.
27. Haney M., Maccari R., Le Moal M., Simon H., Piazza P. V. Brain Res. 698:1995;46-52.
28. Miczek K. A., Mutscheler N. H. Psychopharmacology. 128:1996;256-264.
29. Piazza P. V. et al. Wilner P., Scheel-Kruger J. The Mesolimbic Dopamine System: From Motivation to Action. 1991;473-495 Wiley.
30. Maccari S. et al. Brain Res. 547:1991;7-12.
31. Hadaway P. F., Alexander B. K., Coambs R. B., Beyerstein B. Psychopharmacology. 66:1979;87-91.
32. Marks-Kaufman R., Lewis M. J. Addictive Behav. 9:1984;235-243.
33. Schenck S., Gorman K., Amit Z. Alcohol. 7:1990;321-326.
34. Wolffgramm J., Heyne A. Pharmacol. Biochem. Behav. 38:1991;389-399.
35. Bozarth M. A., Murray A., Wise R. A. Pharmacol. Biochem. Behav. 33:1989;903-907.
36. Alexander B. K., Beyerstein B. L., Hadaway P. F., Coambs R. B. Pharmacol. Biochem. Behav. 15:1981;571-576.
37. Schenk S., Lacelle G., Gorman K., Amit Z. Neurosci. Lett. 81:1987;227-231.
38. Ramsey N. F., Van Ree J. M. Brain Res. 608:1993;216-222.
39. Deminière J. M. et al. Brain Res. 586:1992;135-139.
40. Taylor G. T., Weiss J., Rupich R. Physiol. Behav. 39:1987;429-433.
41. Schenk S., Robinson B., Amit Z. Pharmacol. Biochem. Behav. 31:1988;59-62.
42. Boyle A. E., Smith B. R., Amit Z. Pharmacol. Biochem. Behav. 39:1991;269-274.
43. Phillips G. D. et al. Psychopharmacology. 115:1994;407-418.
44. Shaham Y. Ann. Behav. Med. 18:1996;255-263.
45. Specker S. M., Lac S. T., Carroll M. E. Pharmacol. Biochem. Behav. 48:1994;1025-1029.
46. Kalivas P. W., Stewart J. Brain Res. Rev. 16:1991;223-244.
47. Piazza, P. V. and Le Moal, M. Brain Res. Rev. (in press).
48. Piazza P. V. et al. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8716-8720.
49. Piazza P. V. et al. Proc. Natl. Acad. Sci. U. S. A. 93:1996;15445-15450.
50. Deroche V. et al. J. Neurosci. 15:1995;7181-7188.
51. Rougé-Pont F., Marinelli M., Le Moal M., Simon H., Piazza P. V. J. Neurosci. 15:1995;7189-7195.
52. Piazza P. V. et al. Proc. Natl. Acad. Sci. U. S. A. 88:1991;2088-2092.
53. Deroche V., Marinelli M., Le Moal M., Piazza P. V. J. Pharm. Exp. Ther. 281:1997;1401-1407.
54. Maccari S. et al. J. Neurosci. 15:1995;110-116.
55. Barbazanges A., Piazza P. V., Le Moal M., Maccari S. J. Neurosci. 6:1996;3943-3949.
56. Poulos C. X., Le A. D., Parker J. L. Behav. Pharmacol. 6:1995;810-814.
57. Soubrié P. Behav. Brain Sci. 9:1986;319-335.
58. Shaham Y., Stewart J. Psychopharmacology. 125:1996;385-391.
59. Shaham Y. et al. J. Neurosci. 17:1997;2605-2614.
60. Piazza P. V., Deminière J. M., Le Moal M., Simon H. Science. 245:1989;1511-1513.
61. Hooks M. S., Colvin A. C., Juncos J. L., Justice J. B. Jr Brain Res. 587:1992;306-312.